HIPK2 overexpression leads to stabilization of p53 protein and increased p53 transcriptional activity by decreasing Mdm2 protein levels

BMC Molecular Biology

Volumn 2, Issue , 2001, Pages

  Wang, Ying ^a   Debatin, Klaus Michael ^a   Hug, Hubert ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; MESSENGER RNA; PROTEIN MDM2; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; GENE ACTIVATION; GENE OVEREXPRESSION; GENETIC STABILITY; HUMAN; HUMAN CELL; MUTANT; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; TRANSCRIPTION INITIATION;

EID: 2542500783     PISSN: 14712199     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2199-2-8     Document Type: Article

References (30)

1. Brown JM, Wouters BG: Apoptosis, p53 and tumor cell sensitivity to anticancer agents. Cancer Res. 1999, 59:1391-1399
2. Albrechtsen N, Domreiter I, Grosse F, Kim E, Wiesmüller L, Deppert W: Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. Oncogene 1999, 18:7706-7717
3. Burns TF, El-Deiry WS: The p53 pathway and apoptosis. J. Cell. Physiol. 1999, 181:231-239
4. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331
5. Oren M: Regulation of the p53 tumor suppressor protein. J. Biol. Chem. 1999, 274:36031-36034
6. Kubbutat MH, Jones SN, Vousden KH: Regulation of p53 stability by Mdm2. Nature 1997, 387:299-303
7. Momand J, Wu HH, Dasgupta G: Mdm2-master regulator of the p53 tumor suppressor protein. Gene 2000, 242:15-29
8. Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 2000, 408:307-310
9. Kim YH, Choi CY, Lee S-J, Conti MA, Kim Y: Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J. Biol. Chem. 1998, 273:25875-25879
10. Trost M, Kochs G, Haller O: Characterization of a novel serine/threonine kinase associated with nuclear bodies. J. Biol. Chem. 2000, 275:7373-7377
11. Kirn YH, Choi CY, Kim Y: Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. Proc. Natl. Acad. Sci. USA 1999, 96:12350-12355
12. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B: Definition of a consensus binding site for p53. Nat. Genet. 1992, 1:45-49
13. Tokino T, Thiagalingam S, el-Deiry WS, Waldman T, Kinzler KW, B Vogelstein: P53 tagged sites from human genomic DNA. Hum. Mol. Genet. 1994, 3:1537-1542
14. Hoppe-Seyler F, Butz K: Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human MDM-2, and mutant p53. J. Virol. 1993, 67:3111-3117
15. Marcellus RC, Teodoro JG, Charbonneau R, Shore GC, Branton PE: Expression of p53 in Saos-2 osteosarcoma cells induces apoptosis which can be inhibited by Bcl-2 or the adenovirus E1B-55 kDa protein. Cell Growth Differ. 1996, 7:1643-1650
16. Barak Y, Juven T, Haffher R, Oren M: Mdm2 expression is induced by wild type p53 activity. EMBO J. 1993, 12:461-468
17. Wu X, Bayle JH, Olson D, Levine AJ: The p53-Mdm-2 autoregulatory feedback loop. Genes Dev. 1993, 7:1126-1132
18. Lakin ND, Jackson SP: Regulation of p53 in response to DNA damage. Oncogene 1999, 18:7644-7655
19. Sakaguchi K, Saito S, Higashimoto Y, Roy S, Anderson CW, Appella E: Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J. Biol. Chem. 2000, 275:9278-9283
20. Ashcroft M, Kubbutat MH, Vousden KH: Regulation of p53 function and stability by phosphorylation. Mol. Cell. Biol. 1999, 19:1751-1758
21. Tao W, Levine AJ: Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl. Acad. Sci. USA 1999, 96:3077-3080
22. Geyer RK, Yu ZK, Maki CG: The MDM2 RING-fmger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2000, 2:569-573
23. Melchior F, Hengst L: Mdm2-SUMO1: is bigger better? Nat. Cell Biol. 2000, 2:E161-E163
24. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, T Taniguchi, Tanaka N: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis Science 2000, 288:1053-1058
25. Wang Y, Hofmann TG, Runkel L, Haaf T, Schaller H, K-Debatin M, Hug H: Isolation and characterization of cDNAs for the protein kinase HIPK2. Biochim. Biophys. Acta 2001, 1518:168-172
26. Li X, Wang Y, Debatin K-M, Hug H: The serine/threonine kinase HIPK2 interacts with TRADD, but not with CD95 or TNF-R1 in 293T cells. Biochem. Biophys. Res. Commun. 2000, 277:513-517
27. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and nf-kb activation Cell 1995, 81:495-504
28. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 1998, 281:1305-1308
29. V Rochat-Steiner, Becker K, Micheau O, Schneider P, Bums K, Tschopp J: FIST/HIPK3. A Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits Fas-mediated Jun NH(2)-terminal kinase activation. J. Exp. Med. 2000, 192:1165-1174
30. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ: JNK1: a protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76:1025-103